Antibiotics and risk of breast cancer: Up to 9 years of follow-up of 2.1 million women

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 11, 2006, Pages 2102-2106

  Friedman, Gary D ^a,c   Oestreicher, Nina ^a   Chan, James ^b   Quesenberry Jr , Charles P ^a   Udaltsova, Natalia ^a   Habel, Laurel A ^a  

^a DIVISION OF RESEARCH   (United States)

^b KAISER PERMANENTE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; AZITHROMYCIN; CEPHALOSPORIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; ISONIAZID; LINCOMYCIN; LINCOSAMIDE; MACROLIDE; METRONIDAZOLE; MINOCYCLINE; NITROFURANTOIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM;

ACNE; ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FOLLOW UP; HEALTH CARE; HEALTH PROGRAM; HORMONAL THERAPY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MEDICAL RECORD; OUTPATIENT; PRIORITY JOURNAL; RISK ASSESSMENT; ROSACEA;

ACNE VULGARIS; ADULT; ANTI-BACTERIAL AGENTS; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MACROLIDES; PROPORTIONAL HAZARDS MODELS; RISK; ROSACEA; TETRACYCLINES; TIME FACTORS;

EID: 33845308613     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0401     Document Type: Article

References (20)

1. Velicer CM, Lampe JW, Heckbert SR, Potter JD, Taplin SH. Hypothesis: is antibioltic use associated with breast cancer? Cancer Causes Control 2003;14:739-47.
2. Velicer CM, Heckbert SR, Lampe JW, Potter JD, Robertson CA, Taplin SH. Antibiotic use in relation to risk of breast cancer. JAMA 2004;291:827-35.
3. Knekt P, Adlercreutz H, Rissanen H, Aromaa A, Teppo L, Heliovaara M. Does antibacterial treatment for urinary tract infection contribute to the risk of breast cancer? Br J Cancer 2000;82:1007-10.
4. Sorensen HT, Skriver MV, Frils S, McLaughlin JK, Blot WJ, Baron JA. Use of antibiotics and risk of breast cancer: a population-based case-control study. Br J Cancer 2005;92:594-6.
5. Garcia Rodriguez LA, Gonzalez-Perez A. Use of antibiotics and risk of breast cancer. Am J Epidemiol 2005;161:616-9.
6. Kaye JA, Jick H. Antibiotics and the risk of breast cancer. Epidemiology 2005;16:688-90.
7. Didham RC, Reith DM, McConnell DW, Harrison KS. Antibiotic exposure and breast cancer in New Zealand. Breast Cancer Res Treat 2005;92:163-7.
8. Velicer CM, Heckbert SR, Rutter C, Lampe JW, Malone K. Association between antibiotic use prior to breast cancer diagnosis and breast tumour characteristics (United States). Cancer Causes Control 2006;17:307-13.
9. Friedman GD, Ury HK. Initial screening for carcinogenicity of commonly used drugs. J Natl Cancer Inst 1980;65:723-33.
10. Friedman GD, Ury HK. Screening for possible drug carcinogenicity: second report of findings. J Natl Cancer Inst 1983;71:1165-75.
11. Selby JV, Friedman GD, Fireman BH. Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up. Cancer Res 1989;49:5736-47.
12. Van Den Eeden SK, Friedman GD. Prescription drug screening for subsequent carcinogenicity. Pharmacoepidemiol Drug Saf 1995;4:275-87.
13. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 1992;82:703-10.
14. Oehrli MD, Quesenberry CP, Leyden W. Northern California Cancer Registry: 2005 annual report on trends, incidence, and outcomes. Kaiser Permanente, Northern California Cancer Registry; November, 2005.
15. SAS Institute, Inc. SAS OnlineDoc® 9.1.2. Cary (NC): SAS Institute, Inc.; 2004.
16. Baron JA, Weiderpass E, Newcomb PA, et al. Metabolic disorders and breast cancer risk (United States). Cancer Causes Control 2001;12:875-80.
17. Moseson M, Koenig KL, Shore RE, Pasternack BS. The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol 1993;22:1000-9.
18. Krant MJ, Brandrup CS. Sebaceous gland activity in breast cancer. Nature 1968;217:463-5.
19. Burton JL, Cunliffe WJ, Shuster S. Increase sebum excretion in patients with breast cancer. Br Med J 1970;1:665-6.
20. Goolamali SK, Shuster S. A sebotrophic stimulus in benign and malignant breast disease. Lancet 1975;1:428-9.